Xencor | XNCR - فروش و مدیریت هزینه





فروش و مدیریت هزینه تغییر دادن تاریخ
AbbVie USD 3.89B 325M 2025-12
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
Amgen USD 1.94B 237M 2025-12
Arrowhead Research USD 46.02M 8.84M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Biogen USD 545.2M 38.6M 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Cytokinetics USD 91.72M 67.02M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
J&J USD 6.75B 831M 2025-12
Karyopharm Therapeutics USD 9.56M 17.63M 2025-12
MacroGenics USD 7.94M 1.96M 2025-12
Merck USD 2.85B 215M 2025-12
Novartis USD 3.44B 128M 2025-12
Pfizer USD 4.08B 894M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Xencor USD 17.04M 70.74M 2025-12